COVID-19: disease pathways and gene expression changes predict methylprednisolone can improve outcome in severe cases
暂无分享,去创建一个
Sorin Draghici | Gil Mor | Cordelia Ziraldo | Larry A. Sonna | Raef Fadel | Tuan-Minh Nguyen | Radu Vanciu | Austin Morrison | Rachel M. Kenney | George Alangaden | Mayur Ramesh | S. Drăghici | G. Mor | C. Ziraldo | M. Ramesh | L. A. Sonna | A. Morrison | R. Fadel | T.M. Nguyen | R. Vanciu
[1] D. Annane,et al. Pharmacological principles guiding prolonged glucocorticoid treatment in ARDS , 2020, Intensive Care Medicine.
[2] Linda T. Nieman,et al. Temporal and Spatial Heterogeneity of Host Response to SARS-CoV-2 Pulmonary Infection , 2020, medRxiv.
[3] Nafiseh Saberian,et al. Identification of cell types from single cell data using stable clustering , 2020, Scientific Reports.
[4] M. Montico,et al. Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 Pneumonia , 2020, medRxiv.
[5] R. Schwartz,et al. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19 , 2020, Cell.
[6] Hans Clevers,et al. SARS-CoV-2 productively infects human gut enterocytes , 2020, Science.
[7] J. Ayres,et al. Surviving COVID-19: A disease tolerance perspective , 2020, Science Advances.
[8] T. Jodlowski,et al. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. , 2020, JAMA.
[9] R. Albrecht,et al. SARS-CoV-2 launches a unique transcriptional signature from in vitro, ex vivo, and in vivo systems , 2020, bioRxiv.
[10] Mandeep R. Mehra,et al. COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal , 2020, The Journal of Heart and Lung Transplantation.
[11] Xin Zhou,et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China , 2020, The Journal of Emergency Medicine.
[12] P. Mehta,et al. COVID-19: consider cytokine storm syndromes and immunosuppression , 2020, The Lancet.
[13] J. Baillie,et al. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury , 2020, The Lancet.
[14] Sorin Draghici,et al. Identifying significantly impacted pathways: a comprehensive review and assessment , 2019, Genome Biology.
[15] Sorin Draghici,et al. A new computational drug repurposing method using established disease-drug pair knowledge , 2019, Bioinform..
[16] Sorin Drăghici,et al. Statistics and Data Analysis for Microarrays Using R and Bioconductor , 2016 .
[17] Robert Schechter,et al. Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] Alexander A. Morgan,et al. Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data , 2011, Science Translational Medicine.
[19] Pooja Mittal,et al. A novel signaling pathway impact analysis , 2009, Bioinform..
[20] Purvesh Khatri,et al. A System Biology Approach for the Steady-State Analysis of Gene Signaling Networks , 2007, CIARP.
[21] P. Khatri,et al. A systems biology approach for pathway level analysis. , 2007, Genome research.
[22] Thomas Lengauer,et al. Improved scoring of functional groups from gene expression data by decorrelating GO graph structure , 2006, Bioinform..
[23] Gene Ontology Consortium. The Gene Ontology (GO) database and informatics resource , 2003 .
[24] P. Khatri,et al. Global functional profiling of gene expression. , 2003, Genomics.
[25] Michael Ashburner,et al. On ontologies for biologists: the Gene Ontology--untangling the web. , 2002, Novartis Foundation symposium.
[26] Y. Benjamini,et al. THE CONTROL OF THE FALSE DISCOVERY RATE IN MULTIPLE TESTING UNDER DEPENDENCY , 2001 .
[27] G. Church,et al. Systematic determination of genetic network architecture , 1999, Nature Genetics.
[28] J. Darnell,et al. Interactions between STAT and non-STAT proteins in the interferon-stimulated gene factor 3 transcription complex , 1996, Molecular and cellular biology.
[29] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .